150 related articles for article (PubMed ID: 36205284)
1. Salvage Intrapartum Splenectomy for the Treatment of Transfusion-refractory Anaemia in a ß-thalassemia Intermedia Patient.
Sivrikoz TS; Ozbalak M; Ozmen A; Tukenmez M; Besisik SK
J Coll Physicians Surg Pak; 2022 Oct; 32(10):1344-1346. PubMed ID: 36205284
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy in patients with beta-thalassemia intermedia: outcome of mothers and newborns.
Nassar AH; Usta IM; Rechdan JB; Koussa S; Inati A; Taher AT
Am J Hematol; 2006 Jul; 81(7):499-502. PubMed ID: 16755576
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy in beta-thalassemia intermedia: 20-year experience of a Greek thalassemia center.
Voskaridou E; Balassopoulou A; Boutou E; Komninaka V; Christoulas D; Dimopoulou M; Delaki EE; Loukopoulos D; Terpos E
Eur J Haematol; 2014 Dec; 93(6):492-9. PubMed ID: 24889414
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative blood salvage during cesarean delivery in a patient with beta thalassemia intermedia.
Waters JH; Lukauskiene E; Anderson ME
Anesth Analg; 2003 Dec; 97(6):1808-1809. PubMed ID: 14633564
[TBL] [Abstract][Full Text] [Related]
5. A case of post-splenectomy transfusion-dependent homozygous beta-thalassemia major complicated with myocardial siderosis and osteoporosis and usage of iron-chelating therapy with deferiprone in pregnancy.
Ahmad MF; Zakaria NZ; Arsad N; Chew KT; Abu MA; Shafiee MN; Omar MH
Horm Mol Biol Clin Investig; 2019 Jul; 39(2):. PubMed ID: 31301670
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcomes and iron status in β-thalassemia major and intermedia: a systematic review and meta-analysis.
Vlachodimitropoulou E; Mogharbel H; Kuo KHM; Hwang M; Ward R; Shehata N; Malinowski AK
Blood Adv; 2024 Feb; 8(3):746-757. PubMed ID: 38181780
[TBL] [Abstract][Full Text] [Related]
7. [Current management of thalassemia intermedia].
Thuret I
Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
[TBL] [Abstract][Full Text] [Related]
8. [Splenectomy in a patient with beta thalassemia intermedia and severe hemolytic anemia].
Pérez JA; Padilla J; Rodríguez MA; Cura S; Sánchez S; Cutillas MJ; Sanz J
Rev Esp Anestesiol Reanim; 2001; 48(6):288-91. PubMed ID: 11446945
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for diagnosis and management of Beta-thalassemia intermedia.
Karimi M; Cohan N; De Sanctis V; Mallat NS; Taher A
Pediatr Hematol Oncol; 2014 Oct; 31(7):583-96. PubMed ID: 25247665
[TBL] [Abstract][Full Text] [Related]
10. Predictors of autoimmune hemolytic anemia in beta-thalassemia patients with underlying red blood cells autoantibodies.
Khaled MB; Ouederni M; Sahli N; Dhouib N; Abdelaziz AB; Rekaya S; Kouki R; Kaabi H; Slama H; Mellouli F; Bejaoui M
Blood Cells Mol Dis; 2019 Nov; 79():102342. PubMed ID: 31302454
[TBL] [Abstract][Full Text] [Related]
11. A successful twin pregnancy in a patient with HbE-β-thalassemia in western India.
Merchant R; Italia K; Ahmed J; Ghosh K; Colah RB
J Postgrad Med; 2015; 61(3):203-5. PubMed ID: 26119442
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
Aessopos A; Farmakis D; Deftereos S; Tsironi M; Polonifi A; Moyssakis I; Diamanti-Kandaraki E; Papalambros E
Ann Hematol; 2005 Jun; 84(6):353-7. PubMed ID: 15711802
[TBL] [Abstract][Full Text] [Related]
13. [Chronic pulmonary thromboembolism revealing beta-thalassemia intermedia after splenectomy].
Pierre B; Maillot F; Casset-Sedon D; Regina S; Sitbon O; Cosnay P
Rev Med Interne; 2006 Dec; 27(12):950-3. PubMed ID: 17055118
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome in women with transfused beta-thalassemia in France.
Virot E; Thuret I; Jardel S; Herbrecht R; Lachenal F; Lionnet F; Lucchini MJ; Machin J; Nimubona S; Ribeil JA; Galacteros F; Cannas G; Hot A
Ann Hematol; 2022 Feb; 101(2):289-296. PubMed ID: 34668980
[TBL] [Abstract][Full Text] [Related]
15. Transfusion therapy and alloimmunization in Thalassemia Intermedia: a 10 year experience at a tertiary care university hospital.
Al-Riyami AZ; Al-Mahrooqi S; Al-Hinai S; Al-Hosni S; Al-Madhani A; Daar S
Transfus Apher Sci; 2014 Aug; 51(1):42-6. PubMed ID: 24816438
[TBL] [Abstract][Full Text] [Related]
16. Contemporary approaches to treatment of beta-thalassemia intermedia.
Taher AT; Musallam KM; Karimi M; Cappellini MD
Blood Rev; 2012 Apr; 26 Suppl 1():S24-7. PubMed ID: 22631038
[TBL] [Abstract][Full Text] [Related]
17. Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq.
Amin SS; Jalal SD; Ali KM; Mohammed AI; Rasool LK; Osman TJ
Biomed Res Int; 2020; 2020():2807120. PubMed ID: 32190657
[TBL] [Abstract][Full Text] [Related]
18. Optimal management of β thalassaemia intermedia.
Taher AT; Musallam KM; Cappellini MD; Weatherall DJ
Br J Haematol; 2011 Mar; 152(5):512-23. PubMed ID: 21250971
[TBL] [Abstract][Full Text] [Related]
19. Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).
Rafsanjani KA; Mafi N; Tafreshi RI
Pediatr Hematol Oncol; 2011 Sep; 28(6):497-508. PubMed ID: 21728720
[TBL] [Abstract][Full Text] [Related]
20. β- and α-Thalassemia intermedia in Basra, Southern Iraq.
Abdulwahid DA; Hassan MK
Hemoglobin; 2013; 37(6):553-63. PubMed ID: 23944608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]